文献速递腹部CT

CT上预测胰腺神经内分泌肿瘤切缘状态:NCCN可切除性标准的表现

Predicting resection margin status of pancreatic neuroendocrine tumors on CT: performance of NCCN resectability criteria.
PubMed 文献 · Br J Radiol · 2023-10-24

回顾性纳入80例术前CT并 upfront 手术的胰腺神经内分泌肿瘤患者,由两名放射科医生按NCCN标准评估可切除性(R、BR、UR),R0切除率分别为63.6-64.2%、20.0-33.3%和0%(均p≤0.002),读者间一致性良好(κ=0.74);肿瘤大小和NCCN BR/UR是R1或R2切除的预测因素,R0切除和R病变中较小肿瘤改善无复发生存。

要点

  • NCCN可切除性标准可将PNET分为R0可切除性不同的组:R组R0率63.6-64.2%,BR组20.0-33.3%,UR组0%。
  • 肿瘤大小(<2cm、2-4cm、>4cm)和NCCN BR/UR病变是R1或R2切除的预测因素。
  • R病变中<2cm者R0切除率91.7%,随肿瘤增大而下降。

核心结论

  • NCCN可切除性标准能将PNET患者分层为R0可切除性不同的组,在R病变中加入肿瘤大小可大幅提高R0切除的预测,尤其对<2cm的PNET。

研究设计与样本

  • 回顾性纳入80例有术前CT并接受 upfront 手术的患者,两名放射科医生按NCCN标准评估PNET的可切除性(R、BR、UR),采用逻辑回归分析切缘状态相关因素,κ统计评估读者间一致性,Kaplan-Meier法及log-rank检验估计和比较无复发生存(RFS)。

诊断标准与关键数值

  • R0切除率:R病变63.6-64.2%,BR病变20.0-33.3%,UR病变0%(均p≤0.002),读者间一致性良好(κ=0.74)。
  • 肿瘤大小<2cm、2-4cm、>4cm预测R1或R2切除的OR为9.042-18.110(均p≤0.007);NCCN BR/UR病变预测R1或R2切除的OR为5.918(p=0.032)。
  • R病变中<2cm者R0切除率91.7%,R病变中较大肿瘤R0切除率下降。

临床应用与阅片要点

  • 按NCCN标准将PNET分为R、BR、UR,可帮助预测R0切除的可能性。
  • 在R病变中评估肿瘤大小(<2cm、2-4cm、>4cm)有助于进一步预测R0切除,尤其对<2cm者。
  • R0切除和R病变中较小肿瘤与改善的RFS相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To test the performance of the National Comprehensive Cancer Network (NCCN) CT resectability criteria for predicting the surgical margin status of pancreatic neuroendocrine tumor (PNET) and to identify factors associated with margin-positive resection.

METHODS: Eighty patients with pre-operative CT and upfront surgery were retrospectively enrolled. Two radiologists assessed the CT resectability (resectable [R], borderline resectable [BR], unresectable [UR]) of the PNET according to NCCN criteria. Logistic regression was used to identify factors associated with resection margin status. κ statistics were used to evaluate interreader agreements. Kaplan-Meier method with log-rank test was used to estimate and compare recurrence-free survival (RFS).

RESULTS: Forty-five patients (56.2%) received R0 resection and 35 (43.8%) received R1 or R2 resection. R0 resection rates were 63.6-64.2%, 20.0-33.3%, and 0% for R, BR, and UR diseases, respectively (all p ≤ 0.002), with a good interreader agreement (κ, 0.74). Tumor size (<2 cm, 2-4 cm, and >4 cm; odds ratio (OR), 9.042-18.110; all p ≤ 0.007) and NCCN BR/UR diseases (OR, 5.918; p = 0.032) were predictors for R1 or R2 resection. The R0 resection rate was 91.7% for R disease <2 cm and decreased for larger R disease. R0 resection and smaller tumor size in R disease improved RFS.

CONCLUSION: NCCN resectability criteria can stratify patients with PNET into distinct groups of R0 resectability. Adding tumor size to R disease substantially improves the prediction of R0 resection, especially for PNETs <2 cm.

ADVANCES IN KNOWLEDGE: Tumor size and radiologic resectability independently predicted margin status of PNETs.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Kim DH, Kim B, Chung DJ, et al. Predicting resection margin status of pancreatic neuroendocrine tumors on CT: performance of NCCN resectability criteria. Br J Radiol. 2023. PMID: 37750830. doi:10.1259/bjr.20230503

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。